Clorgyline and Levodopa Oral Inhalation: Interaction Details
A pharmacist-reviewed analysis of the Clorgyline and Levodopa Oral Inhalation
interaction: the documented clinical effects, severity rating, onset, mechanism, and management
considerations, with cited references throughout.
Contraindicated: These should generally not be used together.
Major: Potentially serious — often needs a change or close monitoring.
Moderate: Can be significant — usually manageable with monitoring.
Minor: Usually limited clinical impact.
Evidence grades
Established: Well documented — supported by controlled studies or strong clinical data.
Probable: Good supporting evidence, though not definitively proven.
Suspected: Some evidence suggests this interaction, but it is not well established.
Possible: Limited or conflicting evidence; the interaction may occur.
Theoretical: Predicted from the drugs' pharmacology; not yet confirmed in people.
Ratings come from the documented interaction literature and are reviewed by a
pharmacist. They describe the documented risk of the combination, not what will necessarily
happen to you — your dose, timing, and health picture all matter.
Worried about symptoms right now? Contact your pharmacist or prescriber, or
call Poison Control at 1-800-222-1222 (US). Call 911 for an emergency.
Onset
rapid
hoursweeks
Evidence
theoretical
Severity
Contraindicated
What happens
Hypertension
Interaction Deep Dive
Concurrent administration of levodopa with monoamine oxidase inhibitors (MAOIs) has resulted in hypertensive reactions21, and therefore is contraindicated 3.
This information is for education, not a substitute for professional medical advice. Do not start,
stop, or change any medication without talking to your pharmacist or prescriber.